Market
How many countries will adopt 'EnteroMix' by end of 2026?
2
Resolution / Starting Odds
More than 10 countries • 25%
None • 25%
1 to 5 countries • 25%
6 to 10 countries • 25%
International health organizations or major news outlets
Story
Russia to Launch Free Cancer Vaccine 'EnteroMix' in 2025, Costs 300,000 Rubles per Dose, Says Andrei Kaprin
Dec 17, 2024, 10:30 AM
Russia has announced the development of a cancer vaccine, which will be launched for free in 2025. The vaccine, referred to as 'EnteroMix', is designed specifically for cancer patients and will be personalized for each individual. Andrei Kaprin, the chief oncologist of the Ministry of Health, stated that the state will incur a cost of 300,000 rubles per dose. The selection process for clinical trial candidates has already begun, as reported by Kaprin on his Telegram channel. This initiative reflects Russia's commitment to making advanced medical treatments accessible to its population.
View original story
Similar markets
Less than 25% • 25%
51% to 75% • 25%
25% to 50% • 25%
More than 75% • 25%
Unsuccessful • 25%
Partially successful • 25%
Successful with expected results • 25%
Results inconclusive • 25%
Brazil • 25%
Other • 25%
China • 25%
India • 25%
Positive • 25%
Neutral • 25%
Negative • 25%
Mixed • 25%
10-14 countries • 25%
1-4 countries • 25%
5-9 countries • 25%
15 or more countries • 25%
Lung Cancer • 25%
Breast Cancer • 25%
Other • 25%
Colorectal Cancer • 25%
No countries • 25%
6 to 10 countries • 25%
1 to 5 countries • 25%
More than 10 countries • 25%
5 to 10 • 25%
More than 15 • 25%
11 to 15 • 25%
Less than 5 • 25%
More than 30 • 25%
21 to 30 • 25%
10 to 20 • 25%
Less than 10 • 25%
21-30 countries • 25%
More than 30 countries • 25%
11-20 countries • 25%
0-10 countries • 25%